ating LIBTAYO
Indications and Usage
LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
https://www.regeneron.com/sites/default/files/Libtayo_FPI.pdf
|
